semaglutide and dialysis in patients with kidney failure obesity undergoing and wishing to be transplanted: A prospective, observational, open‐label study - Vanek - 2024 - Diabetes, Obesity and Metabolism FLOWing with the SemagluTIDE —

"GLP-1 receptor agonists and the risk of thyroid cancer." Diabetes Care

Pros and Cons of GLP Medications GLP medications have changed how we approach weight loss and metabolic health

2004, PubMed 15215484)

So, if you or someone that you love is living in a home that has stairs, and you are recovering from a surgery, you may think that your only option is to temporarily relocate to an assisted living or rehabilitation facility

2022;14(6):e26121

PDE5 inhibitors constitute the first-line treatment, while adjunctive TRT may be considered for hypogonadal non-responders, with careful attention to potential side effects, such as gastrointestinal symptoms, increased blood pressure, and thrombosis [206]